JPRN-jRCTs041210054招募中2 期
A multicenter phase II study in children and adults with newly diagnosed T-cell acute lymphoblastic leukemia - JPLSG-ALL-T19
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- Sato Atsushi
- 入组人数
- 259
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 < 65age old（—）
- 性别
- All
入选标准
- •(1) Diagnosis of T cell ALL
- •(2) Age < 65 years old at diagnosis
- •(3) ECOG performance status (PS) score of 0-2. However, PS scores up to 3 are permitted when the deterioration of PS is thought to be due to leukemia.
- •(4) Sufficient organ function satisfying the laboratory data listed below;
- •i) Direct bilirubin: = or < 2.0 mg/dL
- •ii) Creatinine: = or < 2.0 mg/dL
- •iii) Normal ECG and UCG. Although UCG is not essential, it should be examined when cardiac function may be low. EF = or > 50% when it is examined.
- •iv) SpO2 = or > 94% in room air
- •(5) Written informed consent obtained from patient or guardians.
排除标准
- •(1) BCR-ABL1 positive ALL
- •(2) Down syndrome
- •(3) Intracranial hemorrhage = or > grade 3 in CTCAE v5.0
- •(4) Malignant hypertension
- •(5) Pulmonary fibrosis
- •(6) Interstitial pneumonia
- •(7) Liver cirrhosis
- •(8) Positive anti-HIV antibody or HBs antigen
- •(9) Uncontrolled diabetes
- •(10) Uncontrolled infection
- •(11) Deep thrombosis requiring treatment.
- •(12) Mental disorder that will likely make it impossible to complete treatment according to protocol
- •(13) Active double cancer
- •(14) Pregnant or lactating woman, or high possibility of pregnancy
- •(15) Past History of congenital or acquired immunodeficiency
- •(16) Any inappropriate status judged by physician
研究者
相似试验
已完成
不适用
Phase II Clinical Study on Children and Adolescents/Young Adults with Clear Cell Sarcoma of the KidneyJPRN-UMIN000028428Japan Children's Cancer Group (JCCG)48
招募中
1 期
GNT0006 gene therapy trial in patients with limb-girdle muscular dystrophyFKRP-related limb-girdle muscular dystrophy (LGMD R9)MedDRA version: 20.0Level: PTClassification code: 10028356Term: Muscular dystrophy Class: 100000004850CTIS2023-506677-36-00Atamyo Therapeutics40
进行中（未招募）
1 期
GNT0006 gene therapy trial in patients with limb-girdle muscular dystrophyFKRP-related limb-girdle muscular dystrophy (LGMD R9)MedDRA version: 20.0Level: PTClassification code 10028356Term: Muscular dystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2021-004276-33-DKAtamyo Therapeutics39
进行中（未招募）
不适用
The long-term antibody persistence of GSK Biologicals’ meningo-coccal vaccine GSK134612 in healthy adolescents/adults.Invasive disease caused by Neisseria meningitidis serogroups A, C W-135 and YMedDRA version: 18.0Level: LLTClassification code 10028910Term: Neisseria meningitides meningitisSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10051931Term: Neisseria infection NOSSystem Organ Class: 100000004862EUCTR2012-002718-38-Outside-EU/EEAGlaxoSmithKline Biologicals749
尚未招募
2 期
Gene Xpert XDR-TB Kit EvaluatioCTRI/2019/07/020139Foundation for Innovative New Diagnostics India